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bjectives The aim of this study was to describe the clinical characteristics and the outcomes of
atients 90 years of age or older who were treated with percutaneous coronary intervention (PCI).
ackground There is a paucity of outcomes data among nonagenarians undergoing PCI.
ethods We evaluated the outcomes of all patients 90 years of age or older in the Mayo Clinic PCI
egistry and examined trends over time.
esults Over a period of 19 years, we identiﬁed 138 nonagenarians (66% women; age 92.2  2.0
ears). Mean duration of hospitalization was 3.7  3.1 days, and the median follow-up duration was
.6 years. Ninety-one percent of patients presented with an acute coronary syndrome and under-
ent urgent or emergent revascularization. Technical success rate was 91%. Overall, the frequency
f in-hospital death, Q-wave myocardial infarction, and major adverse cardiac events (composite of
eath, Q-wave myocardial infarction, urgent or emergent coronary artery bypass grafting, and cere-
rovascular accident) were 9.4%, 0.7%, and 12.3%, respectively. The long-term survival of the cohort
as not signiﬁcantly different than that of an age, gender, and calendar year of birth-matched Min-
esota cohort. The cohort was divided into 2 groups according to the time of their intervention:
re-2000 (n  32) and 2000 to 2006 (n  106). The in-hospital mortality decreased markedly: 22%
o 6% (p  0.006), respectively.
onclusions Our study demonstrates that, in carefully selected patients, PCI in contemporary prac-
ice may be performed with high technical success with relatively low mortality and morbidity. Thus,
dvanced age alone must not be considered a contraindication to performing coronary angiography
nd PCI when clear indications are present. (J Am Coll Cardiol Intv 2008;1:692–8) © 2008 by the
merican College of Cardiology Foundation
rom the *Division of Cardiovascular Diseases and Department of Internal Medicine and the †Division of Biostatistics, Mayo
linic College of Medicine and Mayo Foundation, Rochester, Minnesota. Alice K. Jacobs, MD, served as Guest Editor for this
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693he elderly are the most rapidly growing segment of the
.S. population (1,2). Approximately two-thirds of these
ndividuals have cardiovascular disease and approximately
ne-third die as a direct consequence of coronary athero-
clerosis (3). The changing demographics are reflected in
he contemporary practice of interventional cardiology,
here an increasing number of older patients are being
eferred for percutaneous coronary interventions (PCI) (4).
ncreasing age is an important determinant of outcomes
fter percutaneous revascularization (5). However, advances
n technology, procedural techniques, and adjunctive med-
cal therapies have resulted in improvement in procedural
utcomes (4,6). Thus, advanced age by itself is not a
ontraindication to PCI (7), and these days it is not
ncommon for it to be performed in octogenarians. Long-
erm outcomes in octogenarians requiring PCI appears to be
imilar to age-matched cohorts (8), and in selected patients,
n-hospital outcomes are comparable to younger patients
9,10).
As these trends continue, PCI is being performed in a
mall but increasing number of nonagenarians. However,
here is a paucity of outcomes data in this population,
imited to case reports and small series (11–14). These
atients have generally been excluded from randomized
rials (15). As a result, there are no evidence-based
uidelines regarding PCI in the very elderly (16 –18).
hus, the aim of this study was to describe the clinical
haracteristics and the outcomes of patients age 90 years
r older who were treated with PCI at the Mayo Clinic
n Rochester, Minnesota.
ethods
tudy population. Since 1979, all patients undergoing per-
utaneous revascularization at the Mayo Clinic have been
rospectively followed in a registry. The registry includes
emographic, clinical, angiographic, and procedural data.
mmediate and in-hospital events are recorded, and each
atient is surveyed by telephone contact by trained research
oordinators using a standardized questionnaire at 6
onths, 1 year, and then annually after the procedure. All
dverse events are confirmed by reviewing the medical
ecords of the patients followed at our institution and by
ontacting the patients’ physicians and reviewing the hos-
ital records of patients followed elsewhere.
Approval for the present study was obtained from the
nstitutional Review Board of the Mayo Foundation. Inclu-
ion criteria were patients who were 90 years or older at the
ime of their PCI, who had undergone the procedure before
007, and consented to the use of their medical records for
esearch. There were 140 such patients between 1979 and
006 (inclusive). There were no PCIs on nonagenarians
efore 1987. Two patients did not allow use of their records
or research and were excluded. geﬁnitions. The number of diseased coronary arteries was
ssessed in orthogonal views and defined by at least 1
oronary artery with 70% stenosis and 50% stenosis in the
thers. Patients with 50% stenosis in the left main
oronary artery were considered to have 2-vessel disease if
here was right dominance and 3-vessel disease if there was
eft dominance. Major adverse cardiovascular events
MACE), defined as 1 or more of the following: 1)
n-hospital death; 2) Q-wave myocardial infarction (MI); 3)
rgent or emergent coronary artery bypass grafting (CABG)
uring the index hospitalization; and 4) cerebrovascular
ccident defined as transient ischemic attack or stroke. MI
as diagnosed in the presence of 2 of the following 3
riteria: 1) typical chest pain for at least 20 min; 2) elevation
f creatine kinase (or the MB fraction)2 normal; and 3)
new Q-wave on electrocardiogram. In-hospital deaths
ncluded all deaths during the index hospital admission.
rocedural success was defined as a reduction of residual
uminal diameter stenosis to 20% without in-hospital
eath, Q-wave MI, or need for CABG. Technical success
as defined as a reduction of
esidual luminal diameter steno-
is to 20% in the treated seg-
ent. Complete revasculariza-
ion was defined as no residual
tenosis 70% in the left main,
eft anterior descending, the first
iagonal (if 2.5 mm in diam-
ter), circumflex, the first or sec-
nd obtuse marginals (if 2.5
m in diameter), ramus inter-
ediate, and the right coronary
rteries. The analyses of long-
erm outcomes included all-
ause mortality, death or any MI, and the composite end
oint of death, MI, or target lesion revascularization (TLR).
ther procedural complications, such as those related to the
ascular access site were not included in the present analysis.
LR was defined as any attempted percutaneous or surgical
evascularization of the target lesion at any time after the
nitial procedure. The Mayo risk score for determining
eriprocedural complications was calculated for each patient
nd was derived from 7 variables (age, creatinine, ejection
raction, shock, MI within 24 h, heart failure at presenta-
ion, and history of peripheral vascular disease) as described
reviously (19). Shock was defined as prolonged systolic
lood pressure 95 mm Hg in patients not on inotropes or
ntra-aortic balloon pump support or 110 mm Hg in
atients in patients requiring treatment with inotropes or
ntra-aortic balloon pump support. To analyze temporal
rends, the cohort was divided into 2 groups according to
he time of their intervention: pre-January 2000 (n  32)
nd January 2000 to December 2006 (n 106). The second
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
IQR  interquartile range
MACE  major adverse
cardiac events
MI  myocardial infarction
PCI  percutaneous
coronary intervention(s)
TLR  target lesion
revascularizationroup represents contemporary practice.
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694tatistical analysis. Continuous variables, summarized as
ean  SD, were compared between groups with 1-way
nalysis of variance (unless otherwise noted). The interquar-
ile range (IQR) represents the 25th to 75th percentile and
hus represents the middle 50% of the data. Discrete
ariables are presented as frequency (percentages) and com-
ared with Pearson’s chi-square test. Missing values were
xcluded from the denominator in the calculation of per-
entages. Kaplan-Meier methods were used to estimate
urvival rates on follow-up. The survival experience of
atients who survived to discharge was compared with the
xpected survival as estimated by an age, sex, and calendar
ear of birth-matched cohort of the Minnesota white
opulation (20). The smoothed fitted lines used to display
rends were created by fitting a cubic spline, which mini-
izes a linear combination of the sum of squared residuals
nd the integral of the square of the second derivative of the
urve. All hypotheses tests are 2-sided with a 0.05 type-1
rror rate. Analyses were performed using SAS version 9.1
SAS Institute Inc., Cary, North Carolina).
esults
aseline characteristics. The clinical characteristics of the
38 patients included in the analysis are summarized in
able 1. The patients were predominantly women, and the
ast majority presented with an acute coronary syndrome.
roponin T has been routinely measured in our laboratory
rom August 1, 2000, the pre-procedure levels were elevated
n 81% of the 94 subjects with measurements available.
here was a high prevalence of hypertension and hyperlip-
demia. A past history of congestive heart failure, cerebro-
ascular disease, peripheral vascular disease, and prior cor-
nary revascularization was frequently present. The Mayo
isk score ranged from 6 to 22 (median [IQR]: 8 [6 to 10])
or in-hospital MACE, and 4 to 20 (median [IQR]: 8 [5 to
0]) for in-hospital death. The median (IQR) estimated
isks were 6.7% (4.4% to 10.2%) for MACE and 2.2%
0.8% to 4.3%) for death.
ngiographic and procedural characteristics. Table 2 sum-
arizes the angiographic and procedural characteristics.
ost (75%) of patients underwent either urgent or emer-
ent revascularization at the time of presentation; elective
CI was performed in only 25% of the cohort. The majority
88%) had multivessel disease with American College of
ardiology/American Heart Association type B2 or C
ulprit lesions. Coronary thrombus (39%), calcification
63%), and bifurcation (17%) lesions were common. Despite
he lesion complexity, technical success and procedural
uccess rates were 91% and 84%, respectively.
utcomes. One hundred fifteen nonagenarians (83%) had
ollow-up within 1 year, 131 (95%) had follow-up within 18
onths, and all but 1 (99%) had follow-up within 2 years ofhe analysis period. Mean duration of hospitalization was o.7 3.1 days. The frequency of in-hospital death, Q-wave
I, and MACE was 9.4%, 0.7%, and 12.3%, respectively.
he distribution of the Mayo risk score and the associated
n-hospital mortality in each risk category is shown in Table
. Three patients suffered a stroke. From January 2003
nward, patients presenting with acute MI were classified as
ither non–ST-segment elevation MI (n  8) or ST-
egment elevation MI (n  20) in the registry. The
n-hospital mortality for the 2 groups was 0% and 10%,
espectively. The MACE rates were 13% and 15%, respec-
ively. Complete revascularization was achieved in 36% of
atients. Median follow-up duration was 3.6 years (IQR:
.8 to 6.1 years). Mortality at 1, 3, and 5 years was 25%,
1%, and 71%, respectively. The frequency of the combined
nd point of death and any MI was 38%, 53%, and 78%,
espectively. The combined end point of death, MI, CABG,
Table 1. Baseline Clinical Characteristics
Variable, n (%) Overall (N  138)
Age, yrs 92.2 2.0
Male gender 61 (44%)
Diabetes 20 (15%)
Hypertension 104 (78%)
Hypercholesterolemia 70 (59%)
Smoking status
Never 85 (64%)
Former 47 (36%)
Unstable angina 85 (62%)
Acute coronary syndrome (MI 7 days or unstable angina) 125 (91%)
Pre-procedural shock 17 (13%)
Predominant symptom
Chest pain 127 (92%)
CHF 5 (4%)
Other/unknown 6 (4%)
CHF status
Never 75 (60%)
Previous 12 (10%)
Current 39 (31%)
Body mass index, kg/m2 25.2 4.6
Prior PTCA 39 (28%)
Prior CABG 13 (9%)
Peripheral vascular disease 17 (13%)
CVA/TIA 30 (23%)
Average creatinine, mg/dl 1.4 0.7
LVEF measure
40% 39 (28%)
40% 16 (12%)
Not available 83 (60%)
Values are mean SD or n (90). Data on peripheral vascular disease and renal disease were not
recorded in the registry before 1993.
CABG coronary artery bypass grafting; CHF congestive heart failure; CVA cerebrovascu-
lar accident; LVEF left ventricular ejection fraction; MImyocardial infarction; PTCA percu-
taneous transluminal angioplasty; TIA transient ischemic attack.r TLR was 44%, 60%, and 81%, respectively. The long-
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695erm survival of the cohort was not significantly different
ompared with an age, gender, and calendar year of birth-
atched Minnesota cohort (Fig. 1). Furthermore, in the
06 nonagenarians treated in 2000 and after, 48 (45%)
eceived a drug-eluting stent and 56 (53%) received a
are-metal stent. Seven (7%) of those patients received
oth; 9 (8%) received neither. Comparing the 48 drug-
luting stent recipients versus the 49 with bare-metal stent
nly, there is no difference is survival among patients in
hese 2 groups (p  0.93).
rends over time. There has been a progressive increase in
he number of nonagenarians being referred for PCI (Fig.
). The risk profile of the patients, and hence the estimated
eriprocedural risk of death and MACE, as estimated from
he Mayo Clinic risk score, has not changed between the 2
roups (Table 4). However, there has been a marked
eduction in the actual in-hospital mortality (Fig. 2) and
ACE (Table 4) over time. This is most likely due to the
Table 2. Baseline Angiographic and Procedural Characteristics
Variable, n (%) Overall (N  138)
Multivessel disease 113 (88%)
Worst lesion type
A 2 (2%)
B1 8 (7%)
B2 31 (26%)
C 77 (65%)
Urgency of PCI
Elective 35 (25%)
Urgent 68 (49%)
Emergency 35 (25%)
Stent use 113 (82%)
Drug-eluting stent use 48 (35%)
Number of stents placed 1 50 (36%)
GP IIb/IIIa inhibitor use 60 (43%)
Number of vessels treated
1 107 (78%)
2 27 (20%)
3 4 (3%)
Elevated post-procedure troponin, number (%) 88 (91%)
Post-troponin, median (IQR) 0.9 (0.1, 3.4)
GP glycoprotein; IQR interquartile range; PCI percutaneous coronary intervention.
Table 3. Distribution of Mayo Risk Score and the
Expected/Observed Mortality
Risk Category
Very Low
(n  36)
Low
(n  29)
Moderate
(n  45)
High
(n  10)
Very High
(n  18)
Score interval 0–5 6–7 8–10 11–12 13
Expected rate 0.7% 1.2% 3.2% 6.3% 36%
Observed 5.6% 3.4% 8.9% 10% 28%
ratemprovement in technical success and the increasing use of
tents and adjunctive glycoprotein IIb/IIIa inhibitor. Sig-
ificant changes also occurred in the medical therapy that
as prescribed at discharge. The use of cardioprotective
edications such as antiplatelets, beta-blockers, statins, and
ngiotensin-converting enzyme inhibitors increased over
ime, reflecting the accumulating evidence for their efficacy.
hile the use of aspirin, clopidogrel, and beta-blockers was
igh, statins were prescribed to only 51% of the patients.
omparison with octogenarians. When compared with pa-
ients who were in their 80s, nonagenarians were more likely
o have multivessel disease, present with an acute coronary
yndrome, and cardiogenic shock. As expected, the esti-
ated risk for death and MACE by the Mayo risk score was
Figure 1. Long-Term Survival
Long-term survival during follow-up among patients versus age, gender,
and calendar year of birth-matched controls.
Figure 2. Trends in In-Hospital Mortality and Case Volume
Over time there has been a steady increase in the number of nonagenari-
ans undergoing percutaneous coronary intervention, with a decrease in
in-hospital mortality.
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696igher in nonagenarians. However, the actual frequencies of
n-hospital mortality, Q-wave MI, stroke, and the compos-
te end point of MACE were not significantly different in
he 2 groups (Table 4). The use of dual antiplatelet therapy
nd beta-blockers was similar in the octogenarians and
onagenarians, but lipid-lowering therapy was less often
rescribed in the very elderly.
iscussion
he major findings of the present study are that there has a
een a marked increase in the number of nonagenarians
ndergoing percutaneous revascularization, and among
hese patients: 1) PCI is typically performed for an acute
oronary syndrome in the setting of complex lesion mor-
hology; 2) the technical success rate is high (91%); 3) there
as been a marked reduction in-hospital mortality over
ime; and 4) long-term outcomes after discharge are similar
o age- and gender-matched control subjects.
Though nonagenarians represent a small subset of
atients in contemporary practice, there has clearly been
n exponential rise in the number of patients referred
Table 4. Trends in Characteristics and Outcomes
Variable
Pre-2000
(n  32)
Age, yrs 91.6 1.2
Male, n (%) 13 (41%)
Body mass index, kg/m2 25.1 4.6
Hypertension, n (%) 21 (66%)
Diabetes, n (%) 5 (16%)
Prior revascularization, n (%) 8 (25%)
Acute coronary syndrome 31 (97%)
Cardiogenic shock 3 (11%)
Estimated risk of MACE, median (Q1, Q3) (Mayo risk score) 6.7 (4.9, 8.3)
Estimated risk of death, median (Q1, Q3) (Mayo risk score) 1.3 (1.1, 3.7)
Multivessel disease (70/50), n (%) 28 (93%)
Complete revascularization, n (%) 7 (22%)
Stent usage, n (%) 16 (50%)
GP IIb/IIIa use, n (%) 8 (25%)
In-hospital death, n (%) 7 (22%)
In-hospital Q-wave MI, n (%) 0 (0%)
In-hospital stroke, n (%) 0 (0%)
In-hospital CABG, n (%) 0 (0%)
MACE, n (%) 7 (22%)
Medications at discharge, n (%)
Aspirin at discharge 22 (88%)
Plavix at discharge 14 (82%)
Lipid-lowering medication at discharge 5 (20%)
Beta-blocker at discharge 19 (76%)
ACE inhibitor at discharge 8 (33%)
*p value comparison between nonagenarians undergoing PCI 2000 onward compared with all octo
ACE angiotensin-converting enzyme; GP glycoprotein; MACEmajor adverse cardiac evenor percutaneous revascularization in recent years (Fig. 2). mt is a global trend (12) and is likely to continue with the
ging population. This is reflected in the data from the
RUSADE (Can Rapid risk stratification of Unstable
ngina patients Suppress ADverse outcomes with Early
mplementation of the American College of Cardiology/
merican Heart Association Guidelines) registry from
hich data were recently published on the outcomes of
ver 5,000 nonagenarians treated for non–ST-segment
levation acute coronary syndromes (21). These investi-
ators report that these patients have high in-hospital
ortality (12%), but outcomes are better among those
atients treated with guideline-recommended care, which in
he case of acute coronary syndromes involves an invasive
trategy for treating ischemia. In the present study, we have
oted improvement in procedural success rates over time,
ikely due to advances in techniques, operator experience,
nd adjunctive therapy. This has been accompanied by a
eduction in in-hospital mortality and MACE rates (Table
and Fig. 2). Moreover, it is encouraging that during
ollow-up extending up to 7 years after discharge, the
urvival of our patients was similar to an age- and gender-
2000 Onward
(n  106) p Value
80–89 Yr Olds
(n  1,339) p Value*
92.4 2.2 0.07 83.5 2.6
48 (45%) 0.64 735 (55%) 0.06
25.2 4.6 0.98 27.4 4.6 0.001
83 (81%) 0.06 1,092 (85%) 0.39
15 (14%) 0.85 341 (26%) 0.010
37 (35%) 0.29 512 (38%) 0.50
94 (89%) 0.16 1,055 (79%) 0.015
14 (13%) 0.72 70 (5%) 0.001
6.7 (4.4, 12.5) 0.43 4.4 (3.5, 6.7) 0.001
2.2 (0.8, 4.3) 0.56 1.1 (0.6, 2.2) 0.001
85 (87%) 0.33 945 (75%) 0.011
42 (40%) 0.07 605 (45%) 0.26
97 (92%) 0.001 1,237 (92%) 0.75
52 (49%) 0.016 734 (55%) 0.24
6 (6%) 0.006 55 (4%) 0.44
1 (1%) 0.58 9 (1%) 0.75
3 (3%) 0.34 19 (1%) 0.25
0 (0%) 11 (1%) 0.35
10 (9%) 0.06 83 (6%) 0.19
99 (99%) 0.005 1,213 (95%) 0.06
96 (97%) 0.012 1,216 (95%) 0.39
51 (51%) 0.005 832 (65%) 0.004
88 (88%) 0.13 1,067 (83%) 0.23
59 (59%) 0.023 774 (60%) 0.77
ns who underwent percutaneous coronary intervention in the same time period.
25th percentile; Q3 75th percentile; other abbreviations as in Table 1.genariaatched population (Fig. 1).
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697Our study is the largest case series with the longest
ollow-up published to date on the characteristics and
utcomes of nonagenarians treated with PCI. As reported
n prior studies (12,13), PCI in nonagenarians is largely
eing performed in the setting of an acute coronary syn-
rome. Not surprisingly, the very elderly patients have
dvanced atherosclerosis, with 88% having multivessel dis-
ase. The culprit lesions have complex morphology, with
wo-thirds of patients having type C lesions. The adverse
esions characteristic accounts for a procedural success rate
89% in the most recent cohort) that is lower than what is
chieved in general (94%) at our institution (4). However,
espite the high-risk characteristics, the in-hospital mortal-
ty (6%) and MACE (9%) rates in the recent cohort of
onagenarians were not prohibitively high, and not signif-
cantly different from the estimated risk using the Mayo risk
core (Table 3). Moreover, it is notable that the in-hospital
utcomes were similar to those seen in octogenarians who
ere treated during the same time period, despite a higher
requency of multivessel disease, acute coronary syndrome,
nd cardiogenic shock in the nonagenarians. Among pa-
ients in whom PCI was performed for acute MI, the
n-hospital mortality was almost exclusively in those with
T-segment elevation MI compared with those with non–
T-segment elevation MI. It is reassuring to note that the
requency of post-procedure stroke is extremely low in this
ery elderly population in whom antiplatelet and anticoag-
lant therapy might be expected to be associated with a
ignificantly increased risk of bleeding.
The present study complements recent publications de-
cribing the outcomes in nonagenarians undergoing other
ardiovascular surgical procedures. Bridges et al. (22) re-
ently published the experience from the Society of Tho-
acic Surgeons national database of outcomes after cardiac
urgery for coronary artery disease and valvular heart disease
n over 1,000 nonagenarians. They concluded that while
urgical mortality increased with age, reasonable outcomes
ould be achieved with careful selection of patients (22).
owever, the operative mortality for CABG was high at
1.8% and frequency of stroke was 2.9%. Similarly, Baril et
l. (23) have reported their experience in performing endo-
ascular repair of abdominal aortic aneurysms in nonage-
arians and reported a high success rate, although the
erioperative mortality was 11%. These studies, together
ith our data, support the feasibility of performing a wide
pectrum of percutaneous and surgical cardiac procedures in
ery elderly patients.
tudy limitations. Although the data were collected pro-
pectively, this is a retrospective single-center analysis and is
ubject to the limitations of such analyses. It is difficult to
etermine the relative importance of better operator skills,
mprovement in technology, use of stents, and improved
ntiplatelet and other adjunctive therapy that have devel-
ped over the time-frame of the data collection. The studyetting involved a single-center tertiary-care referral center.
urthermore, the study was limited to selected patients
reated with PCI, and we cannot comment on the trends in
utcomes in patients who are managed medically or with
urgical revascularization. Indeed, data from the CRU-
ADE registry confirm that coronary revascularization is
erformed in only a minority (12.6%) of nonagenarians
resenting with non–ST-segment elevation acute coronary
yndromes (21). Due to the retrospective design of the
RUSADE data and the present study, it is not possible to
scertain why certain patients are selected for PCI over
thers. Clearly, they appear to represent a small proportion
f all nonagenarians presenting with an acute coronary
yndrome. The absence of comorbidities is likely to be a
ajor factor that determines selection for revascularization.
urther research efforts are required to characterize which
onagenarians would benefit from revascularization, and to
ome extent this requires the development of methods to
uantify fitness and frailty (24) in the elderly. Finally, the
ontrol population was only matched for age, gender, and
alendar year of birth. Consequently, there may have been
ignificant unmeasured differences between the cases and
ontrol subjects, but it was not possible to match for all
otential variables of interest due to a small number of
onagenarians in the general population.
onclusions
ur study demonstrates that, in carefully selected patients,
CI may be performed with high technical success with
elatively low mortality and morbidity. Thus, advanced age
lone must not be a contraindication for performing coro-
ary angiography and PCI when clear indications are
resent. If current trends continue, it is very likely that in
he coming years we will see a marked increase in the
umber of nonagenarians being referred for PCI.
eprint requests and correspondence: Dr. Abhiram Prasad,
ayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.
-mail: prasad.abhiram@mayo.edu.
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